Karen Santiago Rios
Hematology & Oncology · Cidra, Puerto Rico, PRNPI 1396846119
Payments from drug & device makers
Across 505 payments — averaging $22.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$2K
- Johnson & Johnson$2K
- AstraZeneca$1K
- Merck$849
- AbbVie$777
- Genentech USA, Inc.$746
- plus $4K from 33 others
What the payments were for
- Food & beverage$11,31098%
- Education$2002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 91 | $2,125 |
| Johnson & Johnson(2 entities) | 76 | $1,709 |
| AstraZeneca(2 entities) | 55 | $1,380 |
| Merck | 44 | $849 |
| AbbVie | 26 | $777 |
| Genentech USA, Inc. | 37 | $746 |
| Amgen | 33 | $640 |
| Eli Lilly Export S.A. Puerto Rico Branch | 25 | $544 |
| PBG Puerto Rico LLC | 25 | $526 |
| Sanofi | 15 | $311 |
| Puma Biotechnology, Inc. | 11 | $244 |
| Rigel Pharmaceuticals, Inc. | 3 | $234 |
| Novartis | 8 | $175 |
| Regeneron Healthcare Solutions, Inc. | 6 | $144 |
| Exelixis Inc. | 5 | $121 |
| Bayer Puerto Rico Inc. | 4 | $102 |
| Sobi, Inc | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Blueprint Medicines Corporation | 3 | $80 |
| Tempus AI, Inc | 3 | $63 |
| Incyte Corporation | 3 | $63 |
| Pharmaessentia USA Corporation | 2 | $49 |
| Caris MPI, Inc. | 2 | $49 |
| Bayer | 2 | $43 |
| Clovis Oncology, Inc. | 2 | $42 |
| Taiho Oncology, Inc. | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Seagen Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Bristol Myers Squibb | 1 | $24 |
| Fennec Pharmaceuticals, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Gilead | 1 | $21 |
| Shire North American Group Inc | 1 | $19 |
| Pfizer Pharmaceuticals LLC | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,510 in reported general payments places this provider in the 45th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImbruvicaIbrutinib | 24 | $403,432 |
| Anastrozole | 75 | $1,457 |
| Dexamethasone | 24 | $334 |
| Hydroxyurea | 15 | $319 |
| Ondansetron Hcl | 13 | $151 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Cidra, Puerto Rico
- Mirelis AcostaSan Juan$6.3M
- Hector Velez CortesPonce$3.1M
- Luis FloresSan Juan$2.3M
- Noridza Rivera RodriguezSan Juan$2.1M
- Adelba Torres-LopezSan Juan$1.9M
- Maria Garcia PallasCaguas$1.8M
- Karina Arocho-GonzalezHato Rey$1.1M
- Jose Lozada CostasSan Juan$934K
- Fernando CabanillasSan Juan$916K
- Mayra Rivera FigueroaRio Piedras$745K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.